BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 30479618)

  • 1. Commissioning and Dosimetric Results of an Indigenously Developed Intra-Vaginal Template for Interstitial Plus Intracavitary High dose Rate Image-Guided Brachytherapy of Advanced Cervix Cancer.
    Kaliyaperumal V; Banerjee S; Kataria T; Abraham SK; Kamaraj D; Tamilselvan S; Gupta D; Bisht SS; Narang K; Shishak S
    J Med Phys; 2022; 47(4):322-330. PubMed ID: 36908497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical Analysis of Interfraction Dose Variations of High-Risk Clinical Target Volume and Organs at Risk for Cervical Cancer High-Dose-Rate Brachytherapy.
    Washington B; Randall M; Fabian D; Cheek D; Wang C; Luo W
    Adv Radiat Oncol; 2022; 7(6):101019. PubMed ID: 36110265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMRT as an Alternative Technique for Intracavitary Brachytherapy in Patients with Carcinoma of the Cervix: A Feasibility Study Using Unified Dosimetric Index.
    Balan G; Ramasubramanian V
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3563-3568. PubMed ID: 37898864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of three-dimensional multi-imaging combination in brachytherapy of cervical cancer.
    Zhang Z; Zhang N; Cheng G
    Radiol Med; 2023 May; 128(5):588-600. PubMed ID: 37138200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
    Chi Y; Pan Y; Zhang N; Han D; Guo X; Mao Z; Cheng G
    Front Oncol; 2022; 12():841980. PubMed ID: 35372065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RefineNet-based automatic delineation of the clinical target volume and organs at risk for three-dimensional brachytherapy for cervical cancer.
    Jiang X; Wang F; Chen Y; Yan S
    Ann Transl Med; 2021 Dec; 9(23):1721. PubMed ID: 35071415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of computed tomography- and magnetic resonance imaging-based target delineation for cervical cancer brachytherapy.
    Wang F; Bu L; Wu Q; Jiang X; Wu L; Li Y; Xi B; Lu Z; Yan S
    J Contemp Brachytherapy; 2020 Aug; 12(4):367-374. PubMed ID: 33293976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy.
    Carrasco N; Chimeno J; Adrià-Mora M; Pérez-Calatayud MJ; Ibáñez B; Carmona V; Celada F; Gimeno J; Lliso F; Pérez-Calatayud J
    J Contemp Brachytherapy; 2020 Apr; 12(2):139-146. PubMed ID: 32395138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of graphical optimization and inverse planning simulated annealing for brachytherapy of cervical cancer.
    Tang B; Liu X; Wang X; Kang S; Wang P; Li J; Orlandini LC
    J Contemp Brachytherapy; 2019 Aug; 11(4):379-383. PubMed ID: 31523240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.
    Yin G; Wang P; Lang J; Tian Y; Luo Y; Fan Z; Tam KY
    J Contemp Brachytherapy; 2016 Jun; 8(3):221-32. PubMed ID: 27504132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachytherapy in the treatment of cervical cancer: a review.
    Banerjee R; Kamrava M
    Int J Womens Health; 2014; 6():555-64. PubMed ID: 24920937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of impact of target delineation of computed tomography- and magnetic resonance imaging-guided brachytherapy on dose distribution in cervical cancer.
    Tuntipumiamorn L; Lohasammakul S; Dankulchai P; Nakkrasae P
    J Contemp Brachytherapy; 2018 Oct; 10(5):418-424. PubMed ID: 30479618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric comparison of
    Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
    J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix.
    Patil G; Br KK; Narayanan G
    Cureus; 2022 Jan; 14(1):e21503. PubMed ID: 35223279
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.